DE-ESCALATING THERAPY IN PATIENTS WITH CROHN'S DISEASE RECEIVING ADALIMUMAB: A SUBGROUP ANALYSIS OF THE CALM STUDY

Peter Bossuyt  1     Geert R. D'Haens  2     Remo Panaccione  3     William Sandborn  4     Walter Reinisch  5     Simon Travis  6     Stefan Schreiber  7     Alessandro Armuzzi     Silvio Danese     Sofie Berg     Joel Petersson     Jen-Fue Maa     Ezequiel Neimark     Jean-Frederic Colombel    
1 Imelda General Hospital,Bonheiden,Belgium
2 Academic Medical Center,Amsterdam,Netherlands
3 University of Calgary,Calgary,Canada
4 University of California San Diego,La Jolla,United States
5 Medical University of Vienna,Vienna,Austria
6 Oxford University Hospitals,Oxford,United Kingdom
7 University Hospital Schleswig-Holstein,Kiel,Germany;

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing